Tag: ETF
-
EMA ETF Improves Scientific Advice for Medicines and Vaccines Tackling Public Health Threats
Background: A New Era for Public Health Medicines The European Medicines Agency’s Emergency Task Force (ETF) is reforming how it provides scientific advice to developers working on medicines and vaccines for urgent public health threats. This initiative aims to streamline the path from early development to clinical evidence, with a particular focus on antimicrobial resistance…
-
EMA ETF Refines Scientific Advice for Antimicrobial Resistance Medicines and Public Health Threats
Enhancing Guidance for Medicines in Public Health Emergencies The European Medicines Agency’s (EMA) Emergency Task Force (ETF) is upgrading its approach to providing scientific advice for the most promising medicines and vaccines in development to combat public health threats. This evolution focuses on ensuring that life-saving therapies are developed with robust regulatory input, especially in…
-
Improved Scientific Advice for Medicines Tackling Public Health Threats, Including Antimicrobial Resistance
Raising the Bar for Medicines and Vaccines against Public Health Threats Public health threats evolve rapidly, from novel pathogens to the growing challenge of antimicrobial resistance (AMR). In response, the European Medicines Agency’s Emergency Task Force (ETF) is refining its approach to provide higher-quality, earlier scientific advice for medicines and vaccines under development. The aim…